Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
2008-8-13
pubmed:abstractText
The p21 cyclin-dependent kinase inhibitor was frequently expressed in human malignant pleural mesothelioma (MPM) tissues as well as cell lines. Recent data indicate that p21 keeps tumor cells alive after DNA damage, favoring a survival advantage. In this study, we assessed the possibility of p21 suppression as a therapeutic target for MPM.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5099-107
pubmed:meshHeading
pubmed-meshheading:18698027-Animals, pubmed-meshheading:18698027-Antineoplastic Agents, pubmed-meshheading:18698027-Apoptosis, pubmed-meshheading:18698027-Camptothecin, pubmed-meshheading:18698027-Cell Aging, pubmed-meshheading:18698027-Cell Cycle, pubmed-meshheading:18698027-Cell Line, Tumor, pubmed-meshheading:18698027-Cyclin-Dependent Kinase Inhibitor p21, pubmed-meshheading:18698027-Doxorubicin, pubmed-meshheading:18698027-Drug Resistance, Neoplasm, pubmed-meshheading:18698027-Etoposide, pubmed-meshheading:18698027-Humans, pubmed-meshheading:18698027-Immunoblotting, pubmed-meshheading:18698027-In Situ Nick-End Labeling, pubmed-meshheading:18698027-Male, pubmed-meshheading:18698027-Mesothelioma, pubmed-meshheading:18698027-Mice, pubmed-meshheading:18698027-Mice, Nude, pubmed-meshheading:18698027-RNA Interference, pubmed-meshheading:18698027-Transfection, pubmed-meshheading:18698027-Xenograft Model Antitumor Assays
pubmed:year
2008
pubmed:articleTitle
Enhanced antitumor therapy by inhibition of p21waf1 in human malignant mesothelioma.
pubmed:affiliation
Department of Molecular Pathology and Innovative Therapies, Marche University, Ancona, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't